Chemistry:Pamrevlumab
From HandWiki
Short description: Monoclonal antibody
Monoclonal antibody | |
---|---|
Type | ? |
Source | Human |
Target | CTGF |
Clinical data | |
Other names | FG-3019 |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
UNII | |
KEGG | |
Chemical and physical data | |
Formula | C6492H10018N1718O2086S48 |
Molar mass | 147050.38 g·mol−1 |
Pamrevlumab (INN;[1] development code FG-3019) is a humanized monoclonal antibody designed for the treatment of idiopathic pulmonary fibrosis and pancreatic cancer. It binds to the connective tissue growth factor (CTGF) protein.[2]
This drug was developed by FibroGen, Inc.[3]
References
- ↑ World Health Organization (2015). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 113". WHO Drug Information 29 (2). https://www.who.int/medicines/publications/druginformation/innlists/PL113.pdf.
- ↑ "Pamrevlumab for the treatment of idiopathic pulmonary fibrosis". Expert Opinion on Investigational Drugs 29 (8): 771–777. August 2020. doi:10.1080/13543784.2020.1773790. PMID 32447983.
- ↑ Statement On A Nonproprietary Name Adopted By The USAN Council - Pamrevlumab, American Medical Association.
Original source: https://en.wikipedia.org/wiki/Pamrevlumab.
Read more |